185 related articles for article (PubMed ID: 32156166)
1. Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells.
Poole AT; Sitko CA; Le C; Naus CC; Hill BM; Bushnell EAC; Chen VC
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):672-681. PubMed ID: 32156166
[TBL] [Abstract][Full Text] [Related]
2. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
[TBL] [Abstract][Full Text] [Related]
5. Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.
Nepali K; Hsu TI; Hsieh CM; Lo WL; Lai MJ; Hsu KC; Lin TE; Chuang JY; Liou JP
Eur J Med Chem; 2021 May; 217():113338. PubMed ID: 33744690
[TBL] [Abstract][Full Text] [Related]
6. Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma.
Zhang L; Yang Z; Sang H; Jiang Y; Zhou M; Huang C; Huang C; Wu X; Zhang T; Zhang X; Wan S; Zhang J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1541-1552. PubMed ID: 34238111
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
Szeliga M; Karpińska M; Rola R; Niewiadomy A
Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma.
Gabelloni P; Da Pozzo E; Bendinelli S; Costa B; Nuti E; Casalini F; Orlandini E; Da Settimo F; Rossello A; Martini C
Neuroscience; 2010 Jun; 168(2):514-22. PubMed ID: 20382206
[TBL] [Abstract][Full Text] [Related]
9. Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors.
Yamahana H; Komiya Y; Takino T; Endo Y; Yamada H; Asada C; Uto Y
Chem Pharm Bull (Tokyo); 2021; 69(10):1017-1028. PubMed ID: 34602570
[TBL] [Abstract][Full Text] [Related]
10. Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.
Shi L; Wang Q; Wang H; Zhou H; Li Y; Li X
Bioorg Med Chem; 2013 Dec; 21(24):7752-62. PubMed ID: 24247003
[TBL] [Abstract][Full Text] [Related]
11. A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line.
Mukherjee A; Adhikari N; Jha T
Eur J Med Chem; 2017 Dec; 141():37-50. PubMed ID: 29028530
[TBL] [Abstract][Full Text] [Related]
12. Structures/cytotoxicity/selectivity relationship of natural steroidal saponins against GSCs and primary mechanism of tribulosaponin A.
Dai Z; Liu H; Wang B; Yang D; Zhu YY; Yan H; Zhu PF; Liu YP; Chen HC; Zhao YL; Zhao LX; Zhao XD; Liu HY; Luo XD
Eur J Med Chem; 2021 Jan; 210():113068. PubMed ID: 33310292
[TBL] [Abstract][Full Text] [Related]
13. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment.
Nguyen P; Doan P; Rimpilainen T; Konda Mani S; Murugesan A; Yli-Harja O; Candeias NR; Kandhavelu M
J Med Chem; 2021 Aug; 64(15):10908-10918. PubMed ID: 34304559
[TBL] [Abstract][Full Text] [Related]
15. 1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment toward C6 glioma cell line.
Andrade P; Fraga Dias A; Figueiró F; Torres FC; Kawano DF; Oliveira Battastini AM; Carvalho I; Tomich de Paula da Silva CH; Campos JM
Future Med Chem; 2020 Apr; 12(8):689-708. PubMed ID: 32193951
[No Abstract] [Full Text] [Related]
16. Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.
Nuti E; Casalini F; Santamaria S; Gabelloni P; Bendinelli S; Da Pozzo E; Costa B; Marinelli L; La Pietra V; Novellino E; Margarida Bernardo M; Fridman R; Da Settimo F; Martini C; Rossello A
Eur J Med Chem; 2011 Jul; 46(7):2617-29. PubMed ID: 21514700
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9.
Lobo G; Monasterios M; Rodrigues J; Gamboa N; Capparelli MV; Martínez-Cuevas J; Lein M; Jung K; Abramjuk C; Charris J
Eur J Med Chem; 2015; 96():281-95. PubMed ID: 25899333
[TBL] [Abstract][Full Text] [Related]
19. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells
Su RY; Hsueh SC; Chen CY; Hsu MJ; Lu HF; Peng SF; Chen PY; Lien JC; Chen YL; Chueh FS; Chung JG; Yeh MY; Huang YP
Anticancer Res; 2021 Apr; 41(4):1859-1870. PubMed ID: 33813391
[TBL] [Abstract][Full Text] [Related]
20. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
Xiong DD; Xu WQ; He RQ; Dang YW; Chen G; Luo DZ
Oncol Rep; 2019 Apr; 41(4):2194-2208. PubMed ID: 30816530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]